Skip to main content

Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury.

Gerhardt W, Nordin G, Herbert AK, Burzell BL, Isaksson A, Gustavsson E, Haglund S, Müller-Bardorff M, Katus HA

Publication: Clin Chem (2000) • Vol 46 • Page 817-21PMID: 10839770View on PubMed

Purpose

The purpose of this paper was to determine the effects of collection tube type and heparin dose on plasma and serum levels of cardiac troponin T (cTnT) and troponin I (TnI).

Conclusion

The plasma to serum cTnT ratio was found to be unaffected by collection tube type; however addition of increasing quantities of heparin to serum caused a decrease in cTnT and Tn1 levels that was dependent on myocardial infarct (MI) stage.

Studies (1)

Purpose

The purpose of this study was to determine the effects of collection tube type and heparin dose on plasma and serum levels of cardiac troponin T (cTnT) and troponin I (TnI) in patients at different stages of MI.

Summary of Findings

The plasma to serum cTnT ratio was found to be unaffected by collection tube type; however addition of increasing quantities of heparin to serum caused a highly variable decrease in cTnT and Tn1 levels. The largest losses were found in specimens from patients in early MI stages or in specimens collected within the first 12 h after onset of chest pain. In contrast, the smallest losses occurred in specimens from patients in late MI stages or in specimens collected 48 h after onset of chest pain. The cTnT ratio was found to decline with increasing creatine kinase MB isoenzyme (CKMB) mass.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Cardiovascular Disease
  • Platforms

    ProteinImmunoassay
    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Early MI
    Late MI
    Biospecimen AcquisitionAnticoagulant
    Lithium heparin
    None
    Sodium heparin
    Biospecimen AcquisitionTime of biospecimen collection
    1-12 h after onset of chest pain
    13-48 h after onset of chest pain
    More than 48 h after onset of chest pain
    Biospecimen AcquisitionType of collection container/solution
    BD PET PST
    BD PET PST with gel
    BD SST
    BD glass PST
    BD glass PST with gel
    Greiner Vacuette
    Terumo Venoject SST
    Biospecimen Aliquots and ComponentsBiospecimen components
    450 IU/mL Heparin
    50 IU/mL Heparin
    98 IU/mL Heparin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum